InvestSMART

Starpharma Holdings Limited (ASX: SPL) - Announcements

Current share price for SPL : $0.810 0.015 (1.89%)+

ASX company news and announcements for Starpharma Holdings Limited (SPL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Starpharma Holdings Limited (SPL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Starpharma Holdings Limited (SPL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Starpharma Holdings Limited (SPL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$386 Change in Director's Interest Notice - R Thomas 27 Jan 2016 10:45AM $0.615 $0.810 risen by 31.71%
$386 Appendix 3B 25 Jan 2016 5:28PM $0.620 $0.810 risen by 30.65%
$386 Appendix 3B - SPP 22 Jan 2016 10:43AM $0.635 $0.810 risen by 27.56%
$386 Starpharma raises $1.9M under Share Purchase Plan 20 Jan 2016 11:35AM $0.630 $0.810 risen by 28.57%
$386 Change in Director's Interest Notice - R Thomas 22 Dec 2015 11:05AM $0.730 $0.810 risen by 10.96%
$386 Change in substantial holding 18 Dec 2015 4:24PM $0.750 $0.810 risen by 8%
$386 Share Purchase Plan Offer Documents 16 Dec 2015 12:30PM $0.718 $0.810 risen by 12.89%
$386 Cleansing Statement 16 Dec 2015 10:03AM $0.700 $0.810 risen by 15.71%
$386 Appendix 3B - Share Placement 16 Dec 2015 9:56AM $0.700 $0.810 risen by 15.71%
$386 Starpharma signs MOU for VivaGel condom in China 16 Dec 2015 8:44AM $0.700 $0.810 risen by 15.71%
$386 Change in substantial holding 15 Dec 2015 8:28AM $0.700 $0.810 risen by 15.71%
$386 Starpharma completes A$32 million placement 9 Dec 2015 9:10AM $0.780 $0.810 risen by 3.85%
$386 Trading Halt 7 Dec 2015 8:51AM $0.780 $0.810 risen by 3.85%
$386 Change in Director's Interest Notice - J Fairley 4 Dec 2015 3:20PM $0.780 $0.810 risen by 3.85%
$386 Appendix 3B 4 Dec 2015 3:12PM $0.775 $0.810 risen by 4.52%
$386 Second DEP candidate selected by AstraZeneca 2 Dec 2015 9:03AM $0.775 $0.810 risen by 4.52%
$386 Retirement of Director Peter Jenkins and Appendix 3Z 19 Nov 2015 3:56PM $0.860 $0.810 fallen by 5.81%
$386 2015 AGM results 19 Nov 2015 3:49PM $0.860 $0.810 fallen by 5.81%
$386 AGM - Chair address and CEO presentation 19 Nov 2015 1:47PM $0.885 $0.810 fallen by 8.47%
$386 DEP outperforms leading treatments in ovarian cancer model 16 Nov 2015 10:40AM $0.725 $0.810 risen by 11.72%
$386 Starpharma receives $3.4M R&D tax incentive 12 Nov 2015 11:00AM $0.745 $0.810 risen by 8.72%
$386 Starpharma to present at BioEurope conference 4 Nov 2015 3:09PM $0.690 $0.810 risen by 17.39%
$386 Appendix 4C - Quarterly Cashflow Report 30 Oct 2015 10:51AM $0.680 $0.810 risen by 19.12%
$386 Shareholder Update October 2015 29 Oct 2015 4:36PM $0.675 $0.810 risen by 20%
$386 Notice of Annual General Meeting/Proxy Form 16 Oct 2015 10:25AM $0.755 $0.810 risen by 7.28%

626 - 650 of 888 results

Page 26 of 36

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.